Found 141 results
Filters: Author is de Leon, Mony J  [Clear All Filters]
2021
Swerdlow RH, de Leon MJ, Marcus DL.  2021.  Betahydroxybutyrate Consumption in Autopsy Brain Tissue from Alzheimer's Disease Subjects.. J Alzheimers Dis Rep. 5(1):135-141.
Mehta NH, Sherbansky J, Kamer AR, Carare RO, Butler T, Rusinek H, Chiang GC, Li Y, Strauss S, Saint-Louis LA et al..  2021.  The Brain-Nose Interface: A Potential Cerebrospinal Fluid Clearance Site in Humans.. Front Physiol. 12:769948.
Hategan SI, Kamer SA, Craig RG, Sinescu C, de Leon MJ, Jianu DC, Marian C, Bora BI, Dan T-F, Birdac CD et al..  2021.  Cognitive dysfunction in young subjects with periodontal disease.. Neurol Sci. 42(11):4511-4519.
Barry EF, Loftus JP, Luh W-M, de Leon MJ, Niogi SN, Johnson PJ.  2021.  Diffusion tensor-based analysis of white matter in the healthy aging canine brain.. Neurobiol Aging. 105:129-136.
Ford JN, Sweeney EM, Skafida M, Glynn S, Amoashiy M, Lange DJ, Lin E, Chiang GC, Osborne JR, Pahlajani S et al..  2021.  Heuristic scoring method utilizing FDG-PET statistical parametric mapping in the evaluation of suspected Alzheimer disease and frontotemporal lobar degeneration.. Am J Nucl Med Mol Imaging. 11(4):313-326.
Pascoal TA, Benedet AL, Ashton NJ, Kang MSu, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK et al..  2021.  Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(9):1592-1599.
Seixas AA, Turner AD, Bubu OMichael, Jean-Louis G, de Leon MJ, Osorio RS, Glodzik L.  2021.  Obesity and Race May Explain Differential Burden of White Matter Hyperintensity Load.. Clin Interv Aging. 16:1563-1571.
Kamer AR, Pushalkar S, Gulivindala D, Butler T, Li Y, Annam KRaghava Ch, Glodzik L, Ballman KV, Corby PM, Blennow K et al..  2021.  Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.. Alzheimers Dement (Amst). 13(1):e12172.
Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS.  2021.  Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's.. Contemp Clin Trials. 107:106488.